Quotient Sciences 2023 ESG Report
10 December 2024
Overview
Our ESG commitments are closely aligned with our mission to accelerate the development of new medicines for patients.
We hold ourselves accountable, knowing that ethical practices build trust and resilience. At the start of 2024, the company set five ambitious sustainability goals as part of its corporate strategy, including launching a new diversity, equity, and inclusion training program and engaging with suppliers in order to better understand their own ESG initiatives and targets for improvement.
As highlighted in our inaugural ESG report, compiled with data from 2023, Quotient Sciences and its colleagues have made progress on each of these initiatives over the past year.
